SlideShare ist ein Scribd-Unternehmen logo
1 von 44
Downloaden Sie, um offline zu lesen
TOTAL PARENTRAL
NUTRITION
PRESENTED BY: IRFAN AHMED
PHARM.D 4TH PROF.
AKHTAR SAEED COLLEGE OF PHARMACEUTICAL SCIENCES
components
 History
 Definition
 Indications
 Components of TPN
 calculation
 TPN interventions
 Ordering and administration
 Infusion pumps
 Special considerations during preparations
 Monitoring
 Incompatibilities
History
 In 1960s Drs. Wilmore and Dudrick researched on central venous for growth
in infant, elderly patients with catabolic medical conditions Originally
termed hyperalimentation
 Replaced with TPN, which is more descriptive of the technique
TPN
 IV administration of calories, nitrogen and all other nutrients in sufficient quantities to achieve tissue synthesis and
anabolism.
 Peripheral Parenteral Nutrition
Nutrients are supplied via a peripheral vein, usually a vein in the arm. Another term for PPN is peripheral venous
nutrition (PVN).
 PVN is used when a patient is unable to ingest adequate calories enterally or when central venous nutrition is not
feasible.
 Concentration
 4.25% amino acid+ 10% dextrose
 IV fat emulsion should be run simultaneously with the PVN to minimize thrombophlebitis
THE GOLDEN RULE OF NUTRITION
The gut should always be the preferred route for nutrient administration.
Therefore, parenteral nutrition is indicated generally when there is severe
gastro-intestinal dysfunction (patients who cannot take sufficient food or
feeding formulas by the enteral route) .
Indications
Indicated when adequate nutrition cannot be maintained via GIT. Carcinoma
extensive burns
Geriatric refuse to eat
Young anorexic patients
Surgical patients who should not be fed orally
[NPO]
GIT motility disorder
Severe vomiting, when enteral feeding cannot
be tolerated
Components of TPN and their calculations
 Fluids
 Carbohydrate as dextrose (3.4 kcal/g)
 Protein as amino acids (4 kcal/g)
 lipids (10-11 kcal/g)
 Electrolytes
 Vitamins
 Trace minerals
Components of TPN
 Dextrose and lipids to provide energy.
 70%-85% of calories from dextrose
 Protein for tissue synthesis and repair.
 15%-30% from lipids
 Determine the appropriate amount of calories needed for the patient by
assessing height, weight, ideal body weight and % of weight loss
CALCULATIONS
 Calculation of patient requirements calculated using Harris-Benedict
 Harris-Benedict equation
FOR MEN
 For Men:
 = 66.67+ (13.75 x weight in kg) + (5 x height in cm) - (6.76x age)
 DESIGNING THE TPN FORMULA
Estimate Basal Energy Expenditure (BEE).
For women
 For women the formula is:
 = 655.1 + (9.56 * weight in kg) + (1.86 * height in cm) - (4.68 x age)
Total Daily Expenditure(TDE)
TDE= BEE* Activity*Stress
 Activity
 BED=1.2
 Ambulatory=1.3
 Stress:
 Surgery: 1.2
 Infection: 1.4-1.6
 Trauma: 1.3-1.5
 Burns: 1.5-2.1
Total Daily Expenditure(TDE)
TDE= BEE*Activity*Stress
 non-stressed (ambulatory)- 30 kcal/kg body weight
 mild stress (malnourished)- 35-40kcal/kg body weight
 severe injury or sepsis- 45-60kcal/kg body weight
 severe burns- up to 80kcal/kg body weight
 infants up to 200kcal/kg body weight
Carbohydrates in TPN
 Hydrous Dextrose (glucose)
 Provides 3.4 kcalg-1
 1 L D5W =170 kcal,
 1 L D25W = 850 kcal
 Final dextrose concentrations
 5-10% (peripheral)
 35% (central)
 D5W=252 mOsmL-1,
 D25%=1263 mOsmL-1
Protein requirments
 INSOLUBLE AND UNDIGESTED IN BLOOD.
 Protein- requirements usually estimated empirically.
 non-stressed 0.5-1g/kg mild stress 1.2-1.4 g/kg
 moderate stress 1.5-2.0g/kg
 severe stress 2.0-2.5g/kg
Total prentral nutrition
Total prentral nutrition
Total prentral nutrition
Protein Solutions
 Standard formulas
 EAA (40%) and
 NEAA (60%)
 available as 3-15% solutions
 Protein is provided as a crystalline amino acid solution. 500 ml bottles are
standard.
 Solutions vary in amino acid concentration and amino acid composition
Intra venous lipids
 FAT emulsions
 Only O/W emulsions can be given by IV.
 After 2 weeks of TPN
 Dry scaly skin, hair loss, impaired wound healing
 Fat provides 9 kcal/g
 Components
 soybean (50% linoleic)
 safflower (72%)
 glycerol
 water
 egg yolk phospholipid
Actions Indications Dosage Drug
Incompatibilite
s
Fatty acids in
emulsion
form used as
a source of
calories and
to provide
essential
fatty acids
To prevent
fatty acid
deficiency
for patients
requiring
parenteral
nutrition, and
to reverse a
known
deficency
state
characterize
d by scaly
skin
ADULTS: 100
mg/min for
the first 15-30
min then
increase to
2-3 ml/min if
no reaction.
Give only
500 ml (50
gm) first 24
hrs, in no
reaction
increase
following
day. Do not
exceed
2.5gm/kg/da
y
Do not add
any other
medication to
the infusion.
INTRAVENOUS LIPIDS
 Intravenous lipids have the highest caloric density of any components of
parental nutrition
 Intralipid is composed of soybean oil, egg yolk phospholipids, and glycerol.
The major fatty acids are linoleic 54%, oleic 26%, palmitic 9% and linolenic
8%
 If a patient has been on TPN for 2 weeks
 Dry Scaly Skin,
 Hair loss,
 Impaired Wound healing.
 Soybean-oil emulsion (Intralipid) Safflower-oil emulsion (Liposyn)
Electrolytes:
Guidelines for Electrolyte Requirements
Electrolyte Amount/1000
Calories
Sodium 40-50 mEq
Potassium 30-40 mEq
Chloride 40-50 mEq
Magnesium 8-12 mEq
Calcium 2-5 mEq
Phosphorus 15-25 mEq
Recommended Daily Adult Doses of
Parenteral Trace Elements
Trace Element Dose
Zinc 2.5-4.0 mg
Copper 0.5-1.5 mg
Chromium 10-15 ug
Manganese 150-800 ug
Selenium 40-80 ug
MVI
 A 8000 U
 D 800 U
 E 4 U
 Niacin 80 mg
 B1[Thiamine] 40 mg
 B2[Riboflavin] 8 mg
 C 400 mg
 Folic acid 2 mg
MVI
 Vitamin K & . Vitamin B12
 separately I.M.
 Vitamin K 10 mg week-1
 Vitamin B12 100 g week-1
TPN interventions
 Warm to room temp 1 hr prior to use
 Hang TPN alone
 Dextrose concentration > 10%
 given through a central line
 Change TPN bag and filter every 24 hours
Ordering and Mixing PN Solutions
 The physician writes the Rx TPN prescription.
 The pharmacist mixes the TPN solution using aseptic technique.
Prescriptions are compounded by mixing the solutions at a 1:1 dextrose-to-
amino acid ratio and placing in 1-L bags. Alternatively, lipids can be mixed
with the dextrose/amino acid solution, referred to as the 3-in-1 total
nutrient admixture (TNA).
ADMINISTRATION
 TPN should always be given via an infusion pump.
 The pharmacist may be consulted regarding drug compatibility for
simultaneous administration of two or more drugs through a single lumen of
the catheter.
 Avoid the administration of blood products into the lumen designated for
parenteral nutrition.
 Heparin Flush
 When parenteral nutrition infusion is being cycled, a heparin flush is
needed to maintain patency of central venous catheter when solution is
not infusing.
Initial Considerations
 TPN infusion should start slowly so that the body has time to adapt to both the glucose
load and the hyperosmolarity of the solution, and to avoid fluid overload.
 A pump controls the infusion rate of the TPN solution.
 There are specific steps in the inititiation procedure to follow regarding the initiation of
TPN infusion.
 Infusion Pumps:
 Electronic ambulatory infusion pumps are commonly used in the home setting.
 These pumps are lightweight and portable and can be programmed to deliver
continuous infusions, intermittent infusions or single dose medications.
 Many pumps have the capacity to taper the rate of an infusion.
 Multichannel pumps allow for the administration of several different infusions at one time
Total prentral nutrition
General PN Initiation Procedures
 Start with 1 L of TPN solution during the first 24 hours (42 mL/hr as a start rate)
 Increase volume by 1 liter each day until the desired volume is reached
 Monitor blood glucose and electrolytes closely
 Pump administer TPN at a steady rate
 Don't attempt to catch up if administration gets behind
 Continuous vs. Cyclic TPN
the patient is fed at night.
Cyclic TPN helps prevent hepatotoxicity that can develop with long-term TPN
and the fasting period allows essential fatty acids to be released from fat
stores.
SPECAIL CONSIDERATIONS DURING
PREPARATIONS
 Mechanics of Administering
 Titrate up slowly to allow pancreas to adapt to hypertonic dextrose load
 Give 1/3 of max rate on day 1, 2/3 on day 2 and full infusion on day 3
 Taper to allow pancreas to adapt to withdrawal of hypertonic dextrose
 Infuse D10 if TPN abruptly discontinued
 Use filters (0.22 m).
 Fat can’t run through filters
 CLEAN ROOM
 The clean room is a limited-access area, which is separated from the other pharmacy
operations
 to minimize the potential for contamination. All products are prepared using the Class 100
laminar flow cabinets
IV Admixture Environment
 To provide sterility and pyrogen-free, proper environment is a must
 Prepare admixture under laminar-flow filter
 Air filter through High Efficiency Particulate Air (HEPA) flowing at 90fpm and
remove 99.97% particles of 3 m.
 Air flow either horizontal or vertical
 HEPA filter must be replace every 6 months
 Technician or operators must wash hands, gloved and require gowning
Temperature and pH:
 Temperatures below freezing or above room temperature may result in destabilization of
the lipid emulsion.
 pH below 5.3 or the addition of additives with a pH of 5.0 may also destabilize the emulsion.
 Temperature & calcium-phosphorus stability.
 As the temperature increases, there is an increase in the rate of dissociation of calcium and
phosphorus from their salts. This allows more free calcium and phosphorus to be
precipitated
Labeling:
 The American Society of Enteral and Parenteral Nutrition (ASPEN) addressed the issue of
standard labeling for PN solutions in its recent guidelines. Labels for PN admixtures should
include amount per day of base formula, electrolyte additives, micronutrients and
medications, quantity per liter for those who admix in 1L volumes, and dosing weight.
Auxiliary labels may be helpful when PN orders are written in a different format than the
standard label.
Storage and Packaging
TPN solutions should always be transported and stored under controlled-temperature refrigeration.
 TPN solutions are delivered from the pharmacy to the patient’s home, a cooler with cooler
blocks should be used.
 Refrigerators should be checked to make sure the temperature is constant and that adequate
space is available for storing PN solutions and supplies.
Filtering:
 Use of a filter during the administration of PN solutions may prevent complications arising from
any particulate matter, microprecipitates or microorganisms potentially present.
 A 0.2 -1.2-m filter should be used for TPN solutions with amino acids and dextrose.
 Filters should be replaced every 24 hours.
 A clogged filter, indicates some type of problem with the TPN solution, such as contamination
of the solution, precipitation, cracking or incompatibilities
Total prentral nutrition
Monitoring
 Blood work must be drawn to establish baseline lab values, which include:
 electrolytes,
 creatinine,
 triglycerides,
 BUN,
 phosphorous,
 glucose,
 albumin,
 magnesium,
 CBC + differential,
 carbon dioxide, and
 total protein Thereafter, monitoring can be performed 2-3 times per week.
 other include body weight and temperature.
Monitoring of the TPN Patient
 Acute condition, unstable patient, early
nutrition support
 Electrolytes, BUN, SCr: 3-7 times per week
 Calcium, magnesium, phosphate: 1-3 times per week
 LFT’s, TP, ALB: once weekly or every other week
 Triglycerides: weekely or as appropriate for IV fat emulsion use.
 Stable hospitalized patient,
 prolonged parenteral nutrition support
 Electrolytes, BUN, SCr: 1-3 times per week
 Calcium, magnesium, phosphate: once weekly or every other week
 LFT’s TP, ALB: every 2-4 weeks
 CBC/ differential, PLC RBC indices: every 2-4 weeks
TPN incompatibilities
 Drug incompatibilities, drug-nutrient interactions and destabilization of
lipids can all adversely affect the stability of parenteral nutrition solutions.
 Medications that are incompatible with Parenteral nutrition solutions:
 1. Acyclovir
2. Amphotericin B
3. Diazepam
4. Phenytoin
5. Bactrim
6. Metronidazole
Therapeutic Incompatibility
Antagonistic and synergistic effect
 Penicillin and cortisone antagonize heparin leading to anticoagulant
 An increase in amino acid concentration will decrease Theophylline level
 Anticoagulants drugs are used in TPN in order to reduce or prevent any
tendency toward intravascular or in cardiac clotting
 Physical Complications
Haze detected
 Particles detected
 Color changes,
 Changes from clear to cloudy, Emitting of gas
Chemical Incompatibilities
 Change in pH can change solubility
 Antibiotics can remain active in 24 hours at the pH of 6.5, but at pH 3.5 it will be destroy.
 Potassium Penicillin G buffered at pH 6.0-6.5, when added to dextrose, water or NaCl injection it
must also be at buffer 6.0-6.5 to assure activity of antibiotic
 MINIMIZATION OF INCOMPATIBILITIES
 FRESHLY PREPARED
 FEW ADDITIVES
 KNOWLEDGEABLE
 MAKE THEM AWARE
 ASEPTIC TECHNIQUE
 KEEP FILE
Refernces
 Hospital pharmacy by nadeem irfan bukhari
 www.pharmj.com
 www.nyschp.org/the_pharmacist/0998/09
 Wikipedia
 Pharma.knwldgebank.com
Thank
you

Más contenido relacionado

Was ist angesagt?

Total parenteral nutrition
Total parenteral nutritionTotal parenteral nutrition
Total parenteral nutritionNeethu Satheesan
 
TOTAL PARENTAL NUTRITION
TOTAL PARENTAL NUTRITION TOTAL PARENTAL NUTRITION
TOTAL PARENTAL NUTRITION Rooma Khalid
 
parenteral nutrition
parenteral nutritionparenteral nutrition
parenteral nutritionSumer Yadav
 
Administering TPN
Administering TPNAdministering TPN
Administering TPNsilex13
 
Total parentral nutrition
Total parentral nutritionTotal parentral nutrition
Total parentral nutritionArifa T N
 
Parenteral Nutrition Web
Parenteral Nutrition  WebParenteral Nutrition  Web
Parenteral Nutrition WebRia Pineda
 
3. Complications of parenteral nutrition
3. Complications of parenteral nutrition3. Complications of parenteral nutrition
3. Complications of parenteral nutritionChartwellPA
 
Total parenteral nutrition
Total parenteral nutritionTotal parenteral nutrition
Total parenteral nutritionVinay gowda
 
Total parenteral nutrition
Total parenteral nutritionTotal parenteral nutrition
Total parenteral nutritionVenkatesh Kolla
 
Parenteral nutrition therapy
Parenteral nutrition therapyParenteral nutrition therapy
Parenteral nutrition therapyJoginder Singh
 
Parenteral Nutrition
Parenteral NutritionParenteral Nutrition
Parenteral NutritionDRKUB99
 

Was ist angesagt? (20)

Total parenteral nutrition
Total parenteral nutritionTotal parenteral nutrition
Total parenteral nutrition
 
TOTAL PARENTAL NUTRITION
TOTAL PARENTAL NUTRITION TOTAL PARENTAL NUTRITION
TOTAL PARENTAL NUTRITION
 
parenteral nutrition
parenteral nutritionparenteral nutrition
parenteral nutrition
 
Administering TPN
Administering TPNAdministering TPN
Administering TPN
 
Enteral nutrition method
Enteral nutrition methodEnteral nutrition method
Enteral nutrition method
 
Tpn vs ppn
Tpn vs ppnTpn vs ppn
Tpn vs ppn
 
Total parentral nutrition
Total parentral nutritionTotal parentral nutrition
Total parentral nutrition
 
Parenteral Nutrition Web
Parenteral Nutrition  WebParenteral Nutrition  Web
Parenteral Nutrition Web
 
Total parental nutrition
Total parental nutrition   Total parental nutrition
Total parental nutrition
 
TPN.pptx
TPN.pptxTPN.pptx
TPN.pptx
 
Tpn
TpnTpn
Tpn
 
3. Complications of parenteral nutrition
3. Complications of parenteral nutrition3. Complications of parenteral nutrition
3. Complications of parenteral nutrition
 
Total parenteral nutrition
Total parenteral nutritionTotal parenteral nutrition
Total parenteral nutrition
 
Parentral nutrition
Parentral nutritionParentral nutrition
Parentral nutrition
 
Total parenteral nutrition
Total parenteral nutritionTotal parenteral nutrition
Total parenteral nutrition
 
Parenteral nutrition therapy
Parenteral nutrition therapyParenteral nutrition therapy
Parenteral nutrition therapy
 
Total parenteral nutrition
Total parenteral nutritionTotal parenteral nutrition
Total parenteral nutrition
 
Parenteral Nutrition
Parenteral NutritionParenteral Nutrition
Parenteral Nutrition
 
Enteral nutrition
Enteral nutritionEnteral nutrition
Enteral nutrition
 
Nutrition
NutritionNutrition
Nutrition
 

Andere mochten auch

1.What is tpn and who needs it
1.What is tpn and who needs it1.What is tpn and who needs it
1.What is tpn and who needs itChartwellPA
 
Total parenteral nutrition
Total parenteral nutritionTotal parenteral nutrition
Total parenteral nutritionJitendra Shukla
 
Total parenteral nutrition
Total parenteral nutrition Total parenteral nutrition
Total parenteral nutrition techno UCH
 
Total parentral nutrition
Total parentral nutritionTotal parentral nutrition
Total parentral nutritionsania2014
 
Newborn Parenteral Nutrition
Newborn Parenteral Nutrition Newborn Parenteral Nutrition
Newborn Parenteral Nutrition Elsie Constanza
 
Tpn guideline
Tpn guidelineTpn guideline
Tpn guidelinesoftmail
 
Total enteral nutrition and total parenteral nutrition in critically ill pat...
Total enteral nutrition  and total parenteral nutrition in critically ill pat...Total enteral nutrition  and total parenteral nutrition in critically ill pat...
Total enteral nutrition and total parenteral nutrition in critically ill pat...Prof. Mridul Panditrao
 
Clinical Pharmacokinetics-I [half life, order of kinetics, steady state]
Clinical Pharmacokinetics-I [half life, order of kinetics, steady state]Clinical Pharmacokinetics-I [half life, order of kinetics, steady state]
Clinical Pharmacokinetics-I [half life, order of kinetics, steady state]BADAR UDDIN UMAR
 
Hospital Pharmacy
Hospital PharmacyHospital Pharmacy
Hospital PharmacyNc Das
 
SMALL VOLUME PARENTRALS , MANUFACTURING AND QUALITY CONTROL
SMALL VOLUME PARENTRALS , MANUFACTURING AND QUALITY CONTROLSMALL VOLUME PARENTRALS , MANUFACTURING AND QUALITY CONTROL
SMALL VOLUME PARENTRALS , MANUFACTURING AND QUALITY CONTROLDivya Thakur
 
Total parenteral nutrition
Total parenteral nutritionTotal parenteral nutrition
Total parenteral nutritionvora kun
 
clinical pharmacokinetics
clinical pharmacokineticsclinical pharmacokinetics
clinical pharmacokineticsmubarek ahmedin
 
Disorders of the thyroid gland
Disorders of the thyroid glandDisorders of the thyroid gland
Disorders of the thyroid glandMuthu Rohini
 
Jintan putih ppt
Jintan putih pptJintan putih ppt
Jintan putih pptherbalfood
 
Pharmacovigilanve And Its Importance
Pharmacovigilanve And Its ImportancePharmacovigilanve And Its Importance
Pharmacovigilanve And Its Importanceshubham sinha
 

Andere mochten auch (20)

1.What is tpn and who needs it
1.What is tpn and who needs it1.What is tpn and who needs it
1.What is tpn and who needs it
 
Total parenteral nutrition
Total parenteral nutritionTotal parenteral nutrition
Total parenteral nutrition
 
Peds TPN 2010
Peds TPN  2010Peds TPN  2010
Peds TPN 2010
 
Total parenteral nutrition
Total parenteral nutrition Total parenteral nutrition
Total parenteral nutrition
 
Total parentral nutrition
Total parentral nutritionTotal parentral nutrition
Total parentral nutrition
 
Newborn Parenteral Nutrition
Newborn Parenteral Nutrition Newborn Parenteral Nutrition
Newborn Parenteral Nutrition
 
Total parental nutrition
Total parental nutrition Total parental nutrition
Total parental nutrition
 
Tpn guideline
Tpn guidelineTpn guideline
Tpn guideline
 
IV Drug Incompatibilities
IV Drug IncompatibilitiesIV Drug Incompatibilities
IV Drug Incompatibilities
 
Pediatric Parenteral Nutrition
Pediatric Parenteral Nutrition Pediatric Parenteral Nutrition
Pediatric Parenteral Nutrition
 
Total enteral nutrition and total parenteral nutrition in critically ill pat...
Total enteral nutrition  and total parenteral nutrition in critically ill pat...Total enteral nutrition  and total parenteral nutrition in critically ill pat...
Total enteral nutrition and total parenteral nutrition in critically ill pat...
 
Clinical Pharmacokinetics-I [half life, order of kinetics, steady state]
Clinical Pharmacokinetics-I [half life, order of kinetics, steady state]Clinical Pharmacokinetics-I [half life, order of kinetics, steady state]
Clinical Pharmacokinetics-I [half life, order of kinetics, steady state]
 
parenterals
parenteralsparenterals
parenterals
 
Hospital Pharmacy
Hospital PharmacyHospital Pharmacy
Hospital Pharmacy
 
SMALL VOLUME PARENTRALS , MANUFACTURING AND QUALITY CONTROL
SMALL VOLUME PARENTRALS , MANUFACTURING AND QUALITY CONTROLSMALL VOLUME PARENTRALS , MANUFACTURING AND QUALITY CONTROL
SMALL VOLUME PARENTRALS , MANUFACTURING AND QUALITY CONTROL
 
Total parenteral nutrition
Total parenteral nutritionTotal parenteral nutrition
Total parenteral nutrition
 
clinical pharmacokinetics
clinical pharmacokineticsclinical pharmacokinetics
clinical pharmacokinetics
 
Disorders of the thyroid gland
Disorders of the thyroid glandDisorders of the thyroid gland
Disorders of the thyroid gland
 
Jintan putih ppt
Jintan putih pptJintan putih ppt
Jintan putih ppt
 
Pharmacovigilanve And Its Importance
Pharmacovigilanve And Its ImportancePharmacovigilanve And Its Importance
Pharmacovigilanve And Its Importance
 

Ähnlich wie Total prentral nutrition

Total Parenteral Nutrition
Total Parenteral NutritionTotal Parenteral Nutrition
Total Parenteral Nutritionrakshamhetre
 
Parenteral Nutrition for the oral and maxillofacial surgery patient
 Parenteral Nutrition for the oral and maxillofacial surgery patient Parenteral Nutrition for the oral and maxillofacial surgery patient
Parenteral Nutrition for the oral and maxillofacial surgery patientMaxfac Center
 
Total Parentral Nutrition-Hospital Pharmacy
Total Parentral Nutrition-Hospital PharmacyTotal Parentral Nutrition-Hospital Pharmacy
Total Parentral Nutrition-Hospital PharmacyRiya Mariam
 
total parenteral nutrition
total parenteral nutritiontotal parenteral nutrition
total parenteral nutritionBilalzaibZaib
 
Compounding in hospitals.pptx
Compounding in hospitals.pptxCompounding in hospitals.pptx
Compounding in hospitals.pptxKomal Sathe
 
Total parenteral nutrition.pptx
Total parenteral nutrition.pptxTotal parenteral nutrition.pptx
Total parenteral nutrition.pptxMohammed Aladoofi
 
nutrition in ICU part 2. (Total parenteral nutrition)
nutrition in ICU part 2.   (Total parenteral nutrition)nutrition in ICU part 2.   (Total parenteral nutrition)
nutrition in ICU part 2. (Total parenteral nutrition)charul jakhwal
 
Diet supplementation to patient
Diet supplementation to patientDiet supplementation to patient
Diet supplementation to patientdrmcbansal
 
Parenteralandenteralfeeding or Total parentral nutrition
Parenteralandenteralfeeding or Total parentral nutritionParenteralandenteralfeeding or Total parentral nutrition
Parenteralandenteralfeeding or Total parentral nutritionjinsigeorge
 
Total Parenteral Nutrition.pptx
Total Parenteral Nutrition.pptxTotal Parenteral Nutrition.pptx
Total Parenteral Nutrition.pptxNikethana1
 
Fluid and nutrition management in icu admitted paediatric
Fluid and nutrition management in icu admitted paediatricFluid and nutrition management in icu admitted paediatric
Fluid and nutrition management in icu admitted paediatricMohammad Saiful Islam
 
Parenteral nutrition in neonat
Parenteral nutrition in neonatParenteral nutrition in neonat
Parenteral nutrition in neonatReyad Al_Faky
 

Ähnlich wie Total prentral nutrition (20)

Total Parenteral Nutrition
Total Parenteral NutritionTotal Parenteral Nutrition
Total Parenteral Nutrition
 
Parenteral Nutrition for the oral and maxillofacial surgery patient
 Parenteral Nutrition for the oral and maxillofacial surgery patient Parenteral Nutrition for the oral and maxillofacial surgery patient
Parenteral Nutrition for the oral and maxillofacial surgery patient
 
14ab1t0001 tpn
14ab1t0001   tpn14ab1t0001   tpn
14ab1t0001 tpn
 
Total Parentral Nutrition-Hospital Pharmacy
Total Parentral Nutrition-Hospital PharmacyTotal Parentral Nutrition-Hospital Pharmacy
Total Parentral Nutrition-Hospital Pharmacy
 
14ab1t0001 tpn
14ab1t0001   tpn14ab1t0001   tpn
14ab1t0001 tpn
 
total parenteral nutrition
total parenteral nutritiontotal parenteral nutrition
total parenteral nutrition
 
Compounding in hospitals.pptx
Compounding in hospitals.pptxCompounding in hospitals.pptx
Compounding in hospitals.pptx
 
TOTAL PARENTERAL NUTRITION.pptx
TOTAL PARENTERAL NUTRITION.pptxTOTAL PARENTERAL NUTRITION.pptx
TOTAL PARENTERAL NUTRITION.pptx
 
Total parenteral nutrition.pptx
Total parenteral nutrition.pptxTotal parenteral nutrition.pptx
Total parenteral nutrition.pptx
 
Updated tpn last
Updated tpn lastUpdated tpn last
Updated tpn last
 
nutrition in ICU part 2. (Total parenteral nutrition)
nutrition in ICU part 2.   (Total parenteral nutrition)nutrition in ICU part 2.   (Total parenteral nutrition)
nutrition in ICU part 2. (Total parenteral nutrition)
 
5-6-(TPN).ppt
5-6-(TPN).ppt5-6-(TPN).ppt
5-6-(TPN).ppt
 
Diet supplementation to patient
Diet supplementation to patientDiet supplementation to patient
Diet supplementation to patient
 
Parenteralandenteralfeeding or Total parentral nutrition
Parenteralandenteralfeeding or Total parentral nutritionParenteralandenteralfeeding or Total parentral nutrition
Parenteralandenteralfeeding or Total parentral nutrition
 
Total Parenteral Nutrition.pptx
Total Parenteral Nutrition.pptxTotal Parenteral Nutrition.pptx
Total Parenteral Nutrition.pptx
 
Parenteral nutrition
Parenteral nutrition Parenteral nutrition
Parenteral nutrition
 
Fluid and nutrition management in icu admitted paediatric
Fluid and nutrition management in icu admitted paediatricFluid and nutrition management in icu admitted paediatric
Fluid and nutrition management in icu admitted paediatric
 
Parenteral nutrition in neonat
Parenteral nutrition in neonatParenteral nutrition in neonat
Parenteral nutrition in neonat
 
Sepsis Treatment
Sepsis TreatmentSepsis Treatment
Sepsis Treatment
 
TPN Calculations (1).pptx
TPN Calculations (1).pptxTPN Calculations (1).pptx
TPN Calculations (1).pptx
 

Último

Neutraceuticals, Herb-drug & Herb-food inetractions
Neutraceuticals, Herb-drug & Herb-food inetractionsNeutraceuticals, Herb-drug & Herb-food inetractions
Neutraceuticals, Herb-drug & Herb-food inetractionsPradnya Wadekar
 
Ayurveda research in Hypothyroidism, P
Ayurveda  research  in Hypothyroidism, PAyurveda  research  in Hypothyroidism, P
Ayurveda research in Hypothyroidism, PDr.Shalu Jain
 
Ortho Products Franchise-solace biotech limited
Ortho Products Franchise-solace biotech limitedOrtho Products Franchise-solace biotech limited
Ortho Products Franchise-solace biotech limitedSBL DIGITAL
 
Basic of Thyroid Hormone:- An In-depth Analysis
Basic of Thyroid Hormone:- An In-depth AnalysisBasic of Thyroid Hormone:- An In-depth Analysis
Basic of Thyroid Hormone:- An In-depth AnalysisAshishMaletha2
 
Routine Medicine Laboratory Testing _ CÁC XÉT NGHIỆM THƯỜNG QUY ÁP DỤNG TRON...
Routine Medicine Laboratory Testing  _ CÁC XÉT NGHIỆM THƯỜNG QUY ÁP DỤNG TRON...Routine Medicine Laboratory Testing  _ CÁC XÉT NGHIỆM THƯỜNG QUY ÁP DỤNG TRON...
Routine Medicine Laboratory Testing _ CÁC XÉT NGHIỆM THƯỜNG QUY ÁP DỤNG TRON...DUY NGUYEN PHUC
 
TARGET DELINEATION IN VULVAL CANCER BY DR KANHU
TARGET DELINEATION IN VULVAL CANCER BY DR KANHUTARGET DELINEATION IN VULVAL CANCER BY DR KANHU
TARGET DELINEATION IN VULVAL CANCER BY DR KANHUKanhu Charan
 
TARGET DELINEATION IN CERVIX CANCER BY DR KANHU
TARGET DELINEATION IN CERVIX CANCER BY DR KANHUTARGET DELINEATION IN CERVIX CANCER BY DR KANHU
TARGET DELINEATION IN CERVIX CANCER BY DR KANHUKanhu Charan
 
(IDE)and(IVD),QMS,21 CFR part820 , 801)
(IDE)and(IVD),QMS,21 CFR part820  , 801)(IDE)and(IVD),QMS,21 CFR part820  , 801)
(IDE)and(IVD),QMS,21 CFR part820 , 801)chahattyagi200
 
Range of Secondary Electrons and Electron Build-Up: Impact on Scatter in Homo...
Range of Secondary Electrons and Electron Build-Up: Impact on Scatter in Homo...Range of Secondary Electrons and Electron Build-Up: Impact on Scatter in Homo...
Range of Secondary Electrons and Electron Build-Up: Impact on Scatter in Homo...Dr. Dheeraj Kumar
 
SGK BỆNH LÝ GOUT YHN hay lắm nha aaaa.pdf
SGK BỆNH LÝ GOUT YHN hay lắm nha aaaa.pdfSGK BỆNH LÝ GOUT YHN hay lắm nha aaaa.pdf
SGK BỆNH LÝ GOUT YHN hay lắm nha aaaa.pdfHongBiThi1
 
TARGET DELINEATION IN RECTUM CANCER BY DR KANHU
TARGET DELINEATION IN RECTUM  CANCER BY DR KANHUTARGET DELINEATION IN RECTUM  CANCER BY DR KANHU
TARGET DELINEATION IN RECTUM CANCER BY DR KANHUKanhu Charan
 
Human Skeletal System_By Anupam Das......
Human Skeletal System_By Anupam Das......Human Skeletal System_By Anupam Das......
Human Skeletal System_By Anupam Das......anupamdas2143
 
Thyroid hormones- synthesis, secretion, functions and disorders
Thyroid hormones- synthesis, secretion, functions and disordersThyroid hormones- synthesis, secretion, functions and disorders
Thyroid hormones- synthesis, secretion, functions and disordersSai Sailesh Kumar Goothy
 
Ten lessons learnt as anesthetist.pptx
Ten  lessons  learnt as anesthetist.pptxTen  lessons  learnt as anesthetist.pptx
Ten lessons learnt as anesthetist.pptxtusharchokshi1
 
ANATOMY OF THE CEREBRUM WITH CLINICAL ANATOMY.pptx
ANATOMY OF THE CEREBRUM WITH CLINICAL ANATOMY.pptxANATOMY OF THE CEREBRUM WITH CLINICAL ANATOMY.pptx
ANATOMY OF THE CEREBRUM WITH CLINICAL ANATOMY.pptxsiddharthroy26587
 
CELL BLOCK PREPARATION AND ITS IMPORTANCE
CELL BLOCK PREPARATION AND ITS IMPORTANCECELL BLOCK PREPARATION AND ITS IMPORTANCE
CELL BLOCK PREPARATION AND ITS IMPORTANCEShubhadip Ghosh
 
Cholesterol Biosynthesis and catabolism for MBBS, Lab. MEd. BDS.pptx
Cholesterol Biosynthesis  and catabolism for MBBS, Lab. MEd. BDS.pptxCholesterol Biosynthesis  and catabolism for MBBS, Lab. MEd. BDS.pptx
Cholesterol Biosynthesis and catabolism for MBBS, Lab. MEd. BDS.pptxRajendra Dev Bhatt
 
NECROSIS FOR MBBS FIRST YEAR STUDENTS MADE EASY.pptx
NECROSIS FOR MBBS FIRST YEAR STUDENTS MADE EASY.pptxNECROSIS FOR MBBS FIRST YEAR STUDENTS MADE EASY.pptx
NECROSIS FOR MBBS FIRST YEAR STUDENTS MADE EASY.pptxSizan Thapa
 
SGK VIÊM KHỚP DẠNG THẤP YHN .pdf
SGK VIÊM KHỚP DẠNG THẤP YHN              .pdfSGK VIÊM KHỚP DẠNG THẤP YHN              .pdf
SGK VIÊM KHỚP DẠNG THẤP YHN .pdfHongBiThi1
 

Último (20)

Neutraceuticals, Herb-drug & Herb-food inetractions
Neutraceuticals, Herb-drug & Herb-food inetractionsNeutraceuticals, Herb-drug & Herb-food inetractions
Neutraceuticals, Herb-drug & Herb-food inetractions
 
Ayurveda research in Hypothyroidism, P
Ayurveda  research  in Hypothyroidism, PAyurveda  research  in Hypothyroidism, P
Ayurveda research in Hypothyroidism, P
 
Ortho Products Franchise-solace biotech limited
Ortho Products Franchise-solace biotech limitedOrtho Products Franchise-solace biotech limited
Ortho Products Franchise-solace biotech limited
 
Basic of Thyroid Hormone:- An In-depth Analysis
Basic of Thyroid Hormone:- An In-depth AnalysisBasic of Thyroid Hormone:- An In-depth Analysis
Basic of Thyroid Hormone:- An In-depth Analysis
 
Routine Medicine Laboratory Testing _ CÁC XÉT NGHIỆM THƯỜNG QUY ÁP DỤNG TRON...
Routine Medicine Laboratory Testing  _ CÁC XÉT NGHIỆM THƯỜNG QUY ÁP DỤNG TRON...Routine Medicine Laboratory Testing  _ CÁC XÉT NGHIỆM THƯỜNG QUY ÁP DỤNG TRON...
Routine Medicine Laboratory Testing _ CÁC XÉT NGHIỆM THƯỜNG QUY ÁP DỤNG TRON...
 
TARGET DELINEATION IN VULVAL CANCER BY DR KANHU
TARGET DELINEATION IN VULVAL CANCER BY DR KANHUTARGET DELINEATION IN VULVAL CANCER BY DR KANHU
TARGET DELINEATION IN VULVAL CANCER BY DR KANHU
 
TARGET DELINEATION IN CERVIX CANCER BY DR KANHU
TARGET DELINEATION IN CERVIX CANCER BY DR KANHUTARGET DELINEATION IN CERVIX CANCER BY DR KANHU
TARGET DELINEATION IN CERVIX CANCER BY DR KANHU
 
Oral disorders .pptx
Oral disorders .pptxOral disorders .pptx
Oral disorders .pptx
 
(IDE)and(IVD),QMS,21 CFR part820 , 801)
(IDE)and(IVD),QMS,21 CFR part820  , 801)(IDE)and(IVD),QMS,21 CFR part820  , 801)
(IDE)and(IVD),QMS,21 CFR part820 , 801)
 
Range of Secondary Electrons and Electron Build-Up: Impact on Scatter in Homo...
Range of Secondary Electrons and Electron Build-Up: Impact on Scatter in Homo...Range of Secondary Electrons and Electron Build-Up: Impact on Scatter in Homo...
Range of Secondary Electrons and Electron Build-Up: Impact on Scatter in Homo...
 
SGK BỆNH LÝ GOUT YHN hay lắm nha aaaa.pdf
SGK BỆNH LÝ GOUT YHN hay lắm nha aaaa.pdfSGK BỆNH LÝ GOUT YHN hay lắm nha aaaa.pdf
SGK BỆNH LÝ GOUT YHN hay lắm nha aaaa.pdf
 
TARGET DELINEATION IN RECTUM CANCER BY DR KANHU
TARGET DELINEATION IN RECTUM  CANCER BY DR KANHUTARGET DELINEATION IN RECTUM  CANCER BY DR KANHU
TARGET DELINEATION IN RECTUM CANCER BY DR KANHU
 
Human Skeletal System_By Anupam Das......
Human Skeletal System_By Anupam Das......Human Skeletal System_By Anupam Das......
Human Skeletal System_By Anupam Das......
 
Thyroid hormones- synthesis, secretion, functions and disorders
Thyroid hormones- synthesis, secretion, functions and disordersThyroid hormones- synthesis, secretion, functions and disorders
Thyroid hormones- synthesis, secretion, functions and disorders
 
Ten lessons learnt as anesthetist.pptx
Ten  lessons  learnt as anesthetist.pptxTen  lessons  learnt as anesthetist.pptx
Ten lessons learnt as anesthetist.pptx
 
ANATOMY OF THE CEREBRUM WITH CLINICAL ANATOMY.pptx
ANATOMY OF THE CEREBRUM WITH CLINICAL ANATOMY.pptxANATOMY OF THE CEREBRUM WITH CLINICAL ANATOMY.pptx
ANATOMY OF THE CEREBRUM WITH CLINICAL ANATOMY.pptx
 
CELL BLOCK PREPARATION AND ITS IMPORTANCE
CELL BLOCK PREPARATION AND ITS IMPORTANCECELL BLOCK PREPARATION AND ITS IMPORTANCE
CELL BLOCK PREPARATION AND ITS IMPORTANCE
 
Cholesterol Biosynthesis and catabolism for MBBS, Lab. MEd. BDS.pptx
Cholesterol Biosynthesis  and catabolism for MBBS, Lab. MEd. BDS.pptxCholesterol Biosynthesis  and catabolism for MBBS, Lab. MEd. BDS.pptx
Cholesterol Biosynthesis and catabolism for MBBS, Lab. MEd. BDS.pptx
 
NECROSIS FOR MBBS FIRST YEAR STUDENTS MADE EASY.pptx
NECROSIS FOR MBBS FIRST YEAR STUDENTS MADE EASY.pptxNECROSIS FOR MBBS FIRST YEAR STUDENTS MADE EASY.pptx
NECROSIS FOR MBBS FIRST YEAR STUDENTS MADE EASY.pptx
 
SGK VIÊM KHỚP DẠNG THẤP YHN .pdf
SGK VIÊM KHỚP DẠNG THẤP YHN              .pdfSGK VIÊM KHỚP DẠNG THẤP YHN              .pdf
SGK VIÊM KHỚP DẠNG THẤP YHN .pdf
 

Total prentral nutrition

  • 1. TOTAL PARENTRAL NUTRITION PRESENTED BY: IRFAN AHMED PHARM.D 4TH PROF. AKHTAR SAEED COLLEGE OF PHARMACEUTICAL SCIENCES
  • 2. components  History  Definition  Indications  Components of TPN  calculation  TPN interventions  Ordering and administration  Infusion pumps  Special considerations during preparations  Monitoring  Incompatibilities
  • 3. History  In 1960s Drs. Wilmore and Dudrick researched on central venous for growth in infant, elderly patients with catabolic medical conditions Originally termed hyperalimentation  Replaced with TPN, which is more descriptive of the technique
  • 4. TPN  IV administration of calories, nitrogen and all other nutrients in sufficient quantities to achieve tissue synthesis and anabolism.  Peripheral Parenteral Nutrition Nutrients are supplied via a peripheral vein, usually a vein in the arm. Another term for PPN is peripheral venous nutrition (PVN).  PVN is used when a patient is unable to ingest adequate calories enterally or when central venous nutrition is not feasible.  Concentration  4.25% amino acid+ 10% dextrose  IV fat emulsion should be run simultaneously with the PVN to minimize thrombophlebitis
  • 5. THE GOLDEN RULE OF NUTRITION The gut should always be the preferred route for nutrient administration. Therefore, parenteral nutrition is indicated generally when there is severe gastro-intestinal dysfunction (patients who cannot take sufficient food or feeding formulas by the enteral route) .
  • 6. Indications Indicated when adequate nutrition cannot be maintained via GIT. Carcinoma extensive burns Geriatric refuse to eat Young anorexic patients Surgical patients who should not be fed orally [NPO] GIT motility disorder Severe vomiting, when enteral feeding cannot be tolerated
  • 7. Components of TPN and their calculations  Fluids  Carbohydrate as dextrose (3.4 kcal/g)  Protein as amino acids (4 kcal/g)  lipids (10-11 kcal/g)  Electrolytes  Vitamins  Trace minerals
  • 8. Components of TPN  Dextrose and lipids to provide energy.  70%-85% of calories from dextrose  Protein for tissue synthesis and repair.  15%-30% from lipids  Determine the appropriate amount of calories needed for the patient by assessing height, weight, ideal body weight and % of weight loss
  • 9. CALCULATIONS  Calculation of patient requirements calculated using Harris-Benedict  Harris-Benedict equation
  • 10. FOR MEN  For Men:  = 66.67+ (13.75 x weight in kg) + (5 x height in cm) - (6.76x age)  DESIGNING THE TPN FORMULA Estimate Basal Energy Expenditure (BEE).
  • 11. For women  For women the formula is:  = 655.1 + (9.56 * weight in kg) + (1.86 * height in cm) - (4.68 x age)
  • 12. Total Daily Expenditure(TDE) TDE= BEE* Activity*Stress  Activity  BED=1.2  Ambulatory=1.3  Stress:  Surgery: 1.2  Infection: 1.4-1.6  Trauma: 1.3-1.5  Burns: 1.5-2.1
  • 13. Total Daily Expenditure(TDE) TDE= BEE*Activity*Stress  non-stressed (ambulatory)- 30 kcal/kg body weight  mild stress (malnourished)- 35-40kcal/kg body weight  severe injury or sepsis- 45-60kcal/kg body weight  severe burns- up to 80kcal/kg body weight  infants up to 200kcal/kg body weight
  • 14. Carbohydrates in TPN  Hydrous Dextrose (glucose)  Provides 3.4 kcalg-1  1 L D5W =170 kcal,  1 L D25W = 850 kcal  Final dextrose concentrations  5-10% (peripheral)  35% (central)  D5W=252 mOsmL-1,  D25%=1263 mOsmL-1
  • 15. Protein requirments  INSOLUBLE AND UNDIGESTED IN BLOOD.  Protein- requirements usually estimated empirically.  non-stressed 0.5-1g/kg mild stress 1.2-1.4 g/kg  moderate stress 1.5-2.0g/kg  severe stress 2.0-2.5g/kg
  • 19. Protein Solutions  Standard formulas  EAA (40%) and  NEAA (60%)  available as 3-15% solutions  Protein is provided as a crystalline amino acid solution. 500 ml bottles are standard.  Solutions vary in amino acid concentration and amino acid composition
  • 20. Intra venous lipids  FAT emulsions  Only O/W emulsions can be given by IV.  After 2 weeks of TPN  Dry scaly skin, hair loss, impaired wound healing  Fat provides 9 kcal/g  Components  soybean (50% linoleic)  safflower (72%)  glycerol  water  egg yolk phospholipid
  • 21. Actions Indications Dosage Drug Incompatibilite s Fatty acids in emulsion form used as a source of calories and to provide essential fatty acids To prevent fatty acid deficiency for patients requiring parenteral nutrition, and to reverse a known deficency state characterize d by scaly skin ADULTS: 100 mg/min for the first 15-30 min then increase to 2-3 ml/min if no reaction. Give only 500 ml (50 gm) first 24 hrs, in no reaction increase following day. Do not exceed 2.5gm/kg/da y Do not add any other medication to the infusion.
  • 22. INTRAVENOUS LIPIDS  Intravenous lipids have the highest caloric density of any components of parental nutrition  Intralipid is composed of soybean oil, egg yolk phospholipids, and glycerol. The major fatty acids are linoleic 54%, oleic 26%, palmitic 9% and linolenic 8%  If a patient has been on TPN for 2 weeks  Dry Scaly Skin,  Hair loss,  Impaired Wound healing.  Soybean-oil emulsion (Intralipid) Safflower-oil emulsion (Liposyn)
  • 23. Electrolytes: Guidelines for Electrolyte Requirements Electrolyte Amount/1000 Calories Sodium 40-50 mEq Potassium 30-40 mEq Chloride 40-50 mEq Magnesium 8-12 mEq Calcium 2-5 mEq Phosphorus 15-25 mEq
  • 24. Recommended Daily Adult Doses of Parenteral Trace Elements Trace Element Dose Zinc 2.5-4.0 mg Copper 0.5-1.5 mg Chromium 10-15 ug Manganese 150-800 ug Selenium 40-80 ug
  • 25. MVI  A 8000 U  D 800 U  E 4 U  Niacin 80 mg  B1[Thiamine] 40 mg  B2[Riboflavin] 8 mg  C 400 mg  Folic acid 2 mg
  • 26. MVI  Vitamin K & . Vitamin B12  separately I.M.  Vitamin K 10 mg week-1  Vitamin B12 100 g week-1
  • 27. TPN interventions  Warm to room temp 1 hr prior to use  Hang TPN alone  Dextrose concentration > 10%  given through a central line  Change TPN bag and filter every 24 hours
  • 28. Ordering and Mixing PN Solutions  The physician writes the Rx TPN prescription.  The pharmacist mixes the TPN solution using aseptic technique. Prescriptions are compounded by mixing the solutions at a 1:1 dextrose-to- amino acid ratio and placing in 1-L bags. Alternatively, lipids can be mixed with the dextrose/amino acid solution, referred to as the 3-in-1 total nutrient admixture (TNA).
  • 29. ADMINISTRATION  TPN should always be given via an infusion pump.  The pharmacist may be consulted regarding drug compatibility for simultaneous administration of two or more drugs through a single lumen of the catheter.  Avoid the administration of blood products into the lumen designated for parenteral nutrition.  Heparin Flush  When parenteral nutrition infusion is being cycled, a heparin flush is needed to maintain patency of central venous catheter when solution is not infusing.
  • 30. Initial Considerations  TPN infusion should start slowly so that the body has time to adapt to both the glucose load and the hyperosmolarity of the solution, and to avoid fluid overload.  A pump controls the infusion rate of the TPN solution.  There are specific steps in the inititiation procedure to follow regarding the initiation of TPN infusion.  Infusion Pumps:  Electronic ambulatory infusion pumps are commonly used in the home setting.  These pumps are lightweight and portable and can be programmed to deliver continuous infusions, intermittent infusions or single dose medications.  Many pumps have the capacity to taper the rate of an infusion.  Multichannel pumps allow for the administration of several different infusions at one time
  • 32. General PN Initiation Procedures  Start with 1 L of TPN solution during the first 24 hours (42 mL/hr as a start rate)  Increase volume by 1 liter each day until the desired volume is reached  Monitor blood glucose and electrolytes closely  Pump administer TPN at a steady rate  Don't attempt to catch up if administration gets behind  Continuous vs. Cyclic TPN the patient is fed at night. Cyclic TPN helps prevent hepatotoxicity that can develop with long-term TPN and the fasting period allows essential fatty acids to be released from fat stores.
  • 33. SPECAIL CONSIDERATIONS DURING PREPARATIONS  Mechanics of Administering  Titrate up slowly to allow pancreas to adapt to hypertonic dextrose load  Give 1/3 of max rate on day 1, 2/3 on day 2 and full infusion on day 3  Taper to allow pancreas to adapt to withdrawal of hypertonic dextrose  Infuse D10 if TPN abruptly discontinued  Use filters (0.22 m).  Fat can’t run through filters  CLEAN ROOM  The clean room is a limited-access area, which is separated from the other pharmacy operations  to minimize the potential for contamination. All products are prepared using the Class 100 laminar flow cabinets
  • 34. IV Admixture Environment  To provide sterility and pyrogen-free, proper environment is a must  Prepare admixture under laminar-flow filter  Air filter through High Efficiency Particulate Air (HEPA) flowing at 90fpm and remove 99.97% particles of 3 m.  Air flow either horizontal or vertical  HEPA filter must be replace every 6 months  Technician or operators must wash hands, gloved and require gowning
  • 35. Temperature and pH:  Temperatures below freezing or above room temperature may result in destabilization of the lipid emulsion.  pH below 5.3 or the addition of additives with a pH of 5.0 may also destabilize the emulsion.  Temperature & calcium-phosphorus stability.  As the temperature increases, there is an increase in the rate of dissociation of calcium and phosphorus from their salts. This allows more free calcium and phosphorus to be precipitated Labeling:  The American Society of Enteral and Parenteral Nutrition (ASPEN) addressed the issue of standard labeling for PN solutions in its recent guidelines. Labels for PN admixtures should include amount per day of base formula, electrolyte additives, micronutrients and medications, quantity per liter for those who admix in 1L volumes, and dosing weight. Auxiliary labels may be helpful when PN orders are written in a different format than the standard label.
  • 36. Storage and Packaging TPN solutions should always be transported and stored under controlled-temperature refrigeration.  TPN solutions are delivered from the pharmacy to the patient’s home, a cooler with cooler blocks should be used.  Refrigerators should be checked to make sure the temperature is constant and that adequate space is available for storing PN solutions and supplies. Filtering:  Use of a filter during the administration of PN solutions may prevent complications arising from any particulate matter, microprecipitates or microorganisms potentially present.  A 0.2 -1.2-m filter should be used for TPN solutions with amino acids and dextrose.  Filters should be replaced every 24 hours.  A clogged filter, indicates some type of problem with the TPN solution, such as contamination of the solution, precipitation, cracking or incompatibilities
  • 38. Monitoring  Blood work must be drawn to establish baseline lab values, which include:  electrolytes,  creatinine,  triglycerides,  BUN,  phosphorous,  glucose,  albumin,  magnesium,  CBC + differential,  carbon dioxide, and  total protein Thereafter, monitoring can be performed 2-3 times per week.  other include body weight and temperature.
  • 39. Monitoring of the TPN Patient  Acute condition, unstable patient, early nutrition support  Electrolytes, BUN, SCr: 3-7 times per week  Calcium, magnesium, phosphate: 1-3 times per week  LFT’s, TP, ALB: once weekly or every other week  Triglycerides: weekely or as appropriate for IV fat emulsion use.  Stable hospitalized patient,  prolonged parenteral nutrition support  Electrolytes, BUN, SCr: 1-3 times per week  Calcium, magnesium, phosphate: once weekly or every other week  LFT’s TP, ALB: every 2-4 weeks  CBC/ differential, PLC RBC indices: every 2-4 weeks
  • 40. TPN incompatibilities  Drug incompatibilities, drug-nutrient interactions and destabilization of lipids can all adversely affect the stability of parenteral nutrition solutions.  Medications that are incompatible with Parenteral nutrition solutions:  1. Acyclovir 2. Amphotericin B 3. Diazepam 4. Phenytoin 5. Bactrim 6. Metronidazole
  • 41. Therapeutic Incompatibility Antagonistic and synergistic effect  Penicillin and cortisone antagonize heparin leading to anticoagulant  An increase in amino acid concentration will decrease Theophylline level  Anticoagulants drugs are used in TPN in order to reduce or prevent any tendency toward intravascular or in cardiac clotting  Physical Complications Haze detected  Particles detected  Color changes,  Changes from clear to cloudy, Emitting of gas
  • 42. Chemical Incompatibilities  Change in pH can change solubility  Antibiotics can remain active in 24 hours at the pH of 6.5, but at pH 3.5 it will be destroy.  Potassium Penicillin G buffered at pH 6.0-6.5, when added to dextrose, water or NaCl injection it must also be at buffer 6.0-6.5 to assure activity of antibiotic  MINIMIZATION OF INCOMPATIBILITIES  FRESHLY PREPARED  FEW ADDITIVES  KNOWLEDGEABLE  MAKE THEM AWARE  ASEPTIC TECHNIQUE  KEEP FILE
  • 43. Refernces  Hospital pharmacy by nadeem irfan bukhari  www.pharmj.com  www.nyschp.org/the_pharmacist/0998/09  Wikipedia  Pharma.knwldgebank.com